Anti-CD70 Monoclonal Antibody ARGX-110

A defucosylated, humanized IgG1 monoclonal antibody directed against the extracellular domain of the human CD70 molecule with potential antineoplastic activity. Upon administration, anti-CD70 monoclonal antibody ARGX-110 selectively binds to, and neutralizes the activity of CD70, which may also induce an antibody-dependent cellular cytotoxicity (ADCC) response against CD70-expressing tumor cells. CD70, the ligand for the costimulatory receptor CD27 and a member of the tumor necrosis factor (TNF) family, is found on a number of solid and hematological tumors. Its overexpression may play an important role in evasion of immune surveillance. (NCI Thesaurus)

YOU MAY ALSO LIKE

Anti-CD70 Antibody-Drug Conjugate MDX-1203

An antibody-drug conjugate (ADC) containing a fully human monoclonal antibody, directed against the extracellular domain of the human CD70 molecule, conjugated to…

Anti-CD7 Monoclonal Antibody

Any monoclonal antibody directed against the cell surface glycoprotein CD7, regardless of the antibody type.

Anti-CD7 Immunotoxin

A toxin linked to an anti-CD7 antibody.

Anti-CD6 Monoclonal Antibody

Any monoclonal antibody directed against the cell surface glycoprotein CD6, regardless of the antibody type.

Anti-CD52 Monoclonal Antibody

Any monoclonal antibody directed against the cell surface glycoprotein CD52, regardless of the antibody type (e.g., rat, mouse, humanized).

Anti-CD5 Monoclonal Antibody

Any monoclonal antibody directed against the cell surface glycoprotein CD5, regardless of the antibody type.